Nevro Corp.
NVRO · NYSE
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.15 | 0.17 | -0.03 |
| FCF Yield | 11.86% | 0.08% | -3.31% | -7.35% |
| EV / EBITDA | -6.89 | -80.08 | -53.99 | -42.57 |
| Quality | ||||
| ROIC | -10.55% | -2.62% | -4.72% | -6.07% |
| Gross Margin | 62.45% | 66.67% | 64.77% | 66.30% |
| Cash Conversion Ratio | -0.35 | -0.18 | 0.42 | 1.30 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.18% | 1.97% | 3.17% | 3.71% |
| Free Cash Flow Growth | 10,212.42% | 101.53% | 70.49% | -114.95% |
| Safety | ||||
| Net Debt / EBITDA | -3.64 | -36.48 | -18.66 | -9.17 |
| Interest Coverage | -7.76 | -1.98 | -3.73 | -4.97 |
| Efficiency | ||||
| Inventory Turnover | 0.38 | 0.27 | 0.29 | 0.28 |
| Cash Conversion Cycle | 240.28 | 344.53 | 317.19 | 328.92 |